2013
DOI: 10.1002/asia.201300202
|View full text |Cite
|
Sign up to set email alerts
|

Increased Efficacies in Magnetofection and Gene Delivery to Hepatocellular Carcinoma Cells with Ternary Organic–Inorganic Hybrid Nanocomposites

Abstract: A magnetic personality: Magnetofection and gene delivery have been investigated in HepG2 cells using ternary organic–inorganic hybrid nanocomposites that contain deferoxamine‐coated iron oxide nanoparticles (NPs), circular plasmid DNA, and branched polyethylenimine (PEI). It was found that the cellular uptake efficacies depend on the ratio of components in PEI/DNA/NP, as assessed by Prussian staining, magnetic resonance imaging, and luciferase expression in the presence and absence of a magnet during transfect… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 11 publications
(5 citation statements)
references
References 24 publications
0
5
0
Order By: Relevance
“…Thus, the diffusion barrier to nucleic acid delivery may be overcome. Via magnetofection the efficiency of gene delivery can be enhanced up to several hundred fold. …”
Section: Introductionmentioning
confidence: 99%
“…Thus, the diffusion barrier to nucleic acid delivery may be overcome. Via magnetofection the efficiency of gene delivery can be enhanced up to several hundred fold. …”
Section: Introductionmentioning
confidence: 99%
“…Such agents are currently under clinical evaluation. [1] Key clinical trials for transcatheter arterial therapy for liver cancer [2][3][4][5] and the recent patents relevant to cancer chemoembolization are being developed. Herein, we describe the use of a hybrid nanoshell/drug/ polymer composite as a chemoembolization agent for transarterial delivery in liver tumors.…”
mentioning
confidence: 99%
“…Electroporation has been used for delivering TRAIL/Apo2L gene to induce apoptosis [145]; the IL-12 gene to induce immune responses to HCC [146,147]; more recently, to deliver mRNA into T-cells to develop specific T-cells for HCC immunotherapy [148]; and GPC-3 CAR-T-cells [149]. Magnetofection has also been used to deliver genes into HCC cell lines combined with ternary organic-inorganic hybrid nanocomposites containing deferoxamine-coated iron oxide nanoparticles, plasmid DNA, and branched polyethyleneimine [150]. Hydrodynamic gene delivery has been used for functional analysis of therapeutic genes and regulatory elements in rodents since its establishment in 1999 [151,152].…”
Section: Non-viral Gene Delivery Using Physical Methodsmentioning
confidence: 99%